about
Hyperbaric oxygen therapy for vascular dementiaHyperbaric oxygen therapy for vascular dementiaA Review of Risk Factors for Cognitive Impairment in Stroke SurvivorsNeuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's diseaseBiphasic mechanisms of neurovascular unit injury and protection in CNS diseasesHospitalization and cognitive decline: Can the nature of the relationship be deciphered?The role of orexin in post-stroke inflammation, cognitive decline, and depressionCognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessmentThe pathobiology of vascular dementiaCognitive assessments for the early diagnosis of dementia after strokeHeterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairThe immunology of stroke: from mechanisms to translationThe Determinants of Dementia After Stroke (DEDEMAS) Study: protocol and pilot data.The common dementias: a pictorial review.Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort.Post-stroke dementia - a comprehensive review.Association between risk factors for vascular dementia and adiponectin.Association between autoimmune rheumatic diseases and the risk of dementiaDuration and frequency of migraines affect cognitive function: evidence from neuropsychological tests and event-related potentialsThe impact of large structural brain changes in chronic stroke patients on the electric field caused by transcranial brain stimulationTowards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus reportSequence Analysis of Long-Term Readmissions among High-Impact Users of Cerebrovascular Patients.Hyponatremia and increased risk of dementia: A population-based retrospective cohort study.Mortality and nursing care dependency one year after first ischemic stroke: an analysis of German statutory health insurance data.Gender and incidence of dementia in the Framingham Heart Study from mid-adult lifeGenetic polymorphisms of a novel vascular susceptibility gene, Ninjurin2 (NINJ2), are associated with a decreased risk of Alzheimer's disease.Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment.Is apolipoprotein E4 an important risk factor for vascular dementia?Effects of hypoperfusion in Alzheimer's disease.Autoimmune responses to brain following stroke.Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study.Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia.Cognitive state following stroke: the predominant role of preexisting white matter lesions.Meta-analysis of the association between secondhand smoke exposure and stroke.The science of stroke: mechanisms in search of treatments.Cardiovascular risk factors and future risk of Alzheimer's disease.Long-term post-stroke changes include myelin loss, specific deficits in sensory and motor behaviors and complex cognitive impairment detected using active place avoidance.Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trialB-lymphocyte-mediated delayed cognitive impairment following stroke.
P2860
Q24202011-E4A4A591-403A-439A-8BF6-9C6D163F9CB1Q24235434-0BFD9DAD-77C7-4FCE-B0D6-E73806DECA72Q26747191-8F0914B1-74C9-4942-9047-7A68034A00A9Q26750515-8C6F3BC0-1BCD-4855-BD2C-E60A52ACB206Q26827146-A140DBD6-3C66-4E27-ACA5-7C1714DA5652Q26851206-14CCC714-6FDB-4EB7-B4BF-9FA51C403B6FQ26851982-EC0AEC21-AC9D-43C8-857F-5A479EBEB40DQ27003324-E8349064-3483-4A55-AC7E-2A50C5579115Q27006033-445D91DB-4C2E-4A27-ACC4-2C740E2F3473Q27010423-A883C8C6-616C-4B54-B490-07E42AF6085CQ28078211-15CA040F-57D6-4229-B601-695B4A0A1F31Q29620066-289985CA-46FE-4FE0-AD31-383AB242C438Q30653957-FC64192D-4910-4E9A-8FC6-F873AAAC85ACQ30670885-BE4BCD63-93DC-41FA-9F97-91F16FB24A44Q31110501-4768FDE7-8E48-4982-9C8A-CDD962C670EFQ31155081-2233A547-47D4-46C0-A780-6B12BA27B774Q33594133-6912797A-AFA7-417C-8A62-C2CC3C11E683Q33615845-C83DD7C7-ADA1-4361-8B9C-7E0D849F9E50Q33644273-BFB337C4-F991-49BA-9928-286C0318CDB5Q33660513-D53FDCFA-0BB4-4844-89ED-C0EEA82C497DQ33726628-9467C322-6288-4093-84AC-B616302DF377Q33737673-95A348C0-C873-4C99-AD46-2A8018F490B1Q33773240-BB98D49C-1286-4C7B-B615-FDD016A99430Q33857345-EAA57F7C-8412-4F3A-8B93-42666B2EDA7AQ33882491-77F757C5-9A83-4140-ABE1-99018C4E5B18Q33932945-9C5F0323-4FE5-4E3E-8591-FB61911D8C96Q33967781-327FB35B-723B-4A63-A456-1A3125A2B1D2Q34004321-5DEA9F37-4B46-4EED-9B9F-82751B16DB44Q34028845-104A980D-01E5-43C9-96CB-A1E94BBF19AAQ34039966-B55F3AC2-0347-4248-AC71-7D3DE598E6D6Q34049644-7E03F19D-7D2C-4929-B1D4-2C92B97EE8ECQ34058300-75156F4A-18DE-405C-900D-363D7CE282F5Q34075665-D71A09EC-E09D-48F5-A7FA-85BE3E1E0458Q34083840-4F32164B-BA6B-41E0-BC60-4931FC76BCC3Q34172188-44323CEF-EB35-44BD-9DB4-89D1078E5226Q34212337-68180122-78BA-4DA8-B8AC-F7A4309303F0Q34484531-D360D598-9C54-467B-85CA-4AD55BA3968DQ34625542-8FC6156E-74BC-4B63-AE53-D173749044CBQ34837879-5D0B9051-6603-48C9-B9F2-AB3995C6C43CQ35044819-40B13B49-B2F7-4D93-9ADE-576CD6DFEB7D
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Poststroke dementia.
@ast
Poststroke dementia.
@en
Poststroke dementia.
@nl
type
label
Poststroke dementia.
@ast
Poststroke dementia.
@en
Poststroke dementia.
@nl
prefLabel
Poststroke dementia.
@ast
Poststroke dementia.
@en
Poststroke dementia.
@nl
P2093
P1433
P1476
Poststroke dementia
@en
P2093
Didier Leys
Hilde Hénon
Marie-Anne Mackowiak-Cordoliani
P304
P356
10.1016/S1474-4422(05)70221-0
P577
2005-11-01T00:00:00Z